Finance

Beta
Lists
RYTM:BMV
Rhythm Pharmaceuticals Inc
MX$1,866.76
0.00%
(0.00) 1D
Nov 18, 11:17:21 AM GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for RYTM...
Mkt. cap
5.92B
Avg. vol.
0.00
Volume
0.00
52-wk high
MX$2,025.00
52-wk low
MX$958.00
No. of employees
414
Mkt. cap
5.92B
Avg. vol.
0.00
Volume
0.00
52-wk high
MX$2,025.00
52-wk low
MX$958.00
No. of employees
414
News stories
From sources across the web
About Rhythm Pharmaceuticals Inc
CEO-
Employees414
FoundedNov 2008
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
48.50M
51.30M
57.25M
60.11M
Cost of goods sold
5.54M
5.50M
4.80M
7.16M
Cost of revenue
5.54M
5.50M
4.80M
7.16M
Research and development expenses
42.31M
46.03M
42.03M
41.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
45.95M
52.42M
57.48M
63.59M
Operating expense
88.26M
98.45M
99.51M
105.32M
Total operating expenses
93.80M
103.95M
104.32M
112.47M
Operating income
-45.30M
-52.65M
-47.06M
-52.36M
Other non operating income
1.58M
274.00K
57.00K
-3.10M
EBT including unusual items
-46.30M
-52.79M
-47.54M
-55.09M
EBT excluding unusual items
-46.30M
-52.79M
-47.54M
-55.09M
Income tax expense
337.00K
111.00K
-31.00K
545.00K
Effective tax rate
-0.73%
-0.21%
0.07%
-0.99%
Other operating expenses
-
-
-
-
Net income
-46.63M
-52.90M
-47.50M
-55.64M
Net profit margin
-96.14%
-103.13%
-82.97%
-92.56%
Earnings per share
-0.75
-0.82
-0.73
-0.83
Interest and investment income
3.24M
4.33M
4.08M
3.55M
Interest expense
-5.82M
-4.74M
-4.62M
-4.58M
Net interest expenses
-2.58M
-414.00K
-530.00K
-1.03M
Depreciation and amortization charges
-
-
-
-
EBITDA
-44.92M
-52.35M
-46.79M
-52.11M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more